Eurofins
NY State Department of Health Approves Eurofins Viracor Transplant Rejection Tests
The Viracor TRAC donor-derived cell-free DNA test and TruGraf blood gene expression test both assess rejection status in kidney transplant recipients.
As SARS-CoV-2 Variants Complicate Efforts to Tame Pandemic, Eurofins Test Helps to ID Mutations
Premium
Eurofins said its new multiplex PCR kit could be impactful for countries looking to gain control of disease clusters triggered by SARS-CoV-2 variants.
Eurofins Scientific Posts 17 Percent Increase in FY2020 Revenues
The company also said that it had received EUA from the US Food and Drug Administration for a non-prescription version of its COVID-19 sample collection kit.
Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test
The test, which was developed by researchers at the Cleveland Clinic and the University of Alabama, looks for RNA molecules in urine that indicate rejection.
Dec 15, 2020
Eurofins Increases 2020 Revenue Guidance to €5.3B
Sep 26, 2019
CareDx Sues Eurofins Viracor for Patent Infringement
Jun 25, 2019
Eurofins Acquires Transplant Genomics
Jun 26, 2017